Article
Author: Oliver, Antonio ; Oviaño, Marina ; Fraile-Ribot, Pablo Arturo ; Gato, Eva ; Gutiérrez-Urbón, José María ; Fernández-Pérez, Begoña ; Vázquez-Ucha, Juan Carlos ; Lasarte-Monterrubio, Cristina ; González-Bello, Concepción ; Alonso-García, Isaac ; Bou, Germán ; Ruedas-López, Alba ; Arca-Suárez, Jorge ; Guijarro-Sánchez, Paula ; Velasco, David ; Beceiro, Alejandro ; Vallejo, Juan Andrés
Infections caused by ceftolozane-tazobactam and ceftazidime-avibactam-resistant
P. aeruginosa
infections are an emerging concern. We aimed to analyze the underlying ceftolozane-tazobactam and ceftazidime-avibactam resistance mechanisms in all multidrug-resistant or extensively drug-resistant (MDR/XDR)
P. aeruginosa
isolates recovered during 1 year (2020) from patients with a documented
P. aeruginosa
infection.